Open Access
Open access
volume 12 issue 11 publication number 1050

Mitochondrial Drp1 recognizes and induces excessive mPTP opening after hypoxia through BAX-PiC and LRRK2-HK2

Publication typeJournal Article
Publication date2021-11-05
scimago Q1
wos Q1
SJR2.773
CiteScore15.4
Impact factor9.6
ISSN20414889
Cancer Research
Cell Biology
Cellular and Molecular Neuroscience
Immunology
Abstract
Mitochondrial mass imbalance is one of the key causes of cardiovascular dysfunction after hypoxia. The activation of dynamin-related protein 1 (Drp1), as well as its mitochondrial translocation, play important roles in the changes of both mitochondrial morphology and mitochondrial functions after hypoxia. However, in addition to mediating mitochondrial fission, whether Drp1 has other regulatory roles in mitochondrial homeostasis after mitochondrial translocation is unknown. In this study, we performed a series of interaction and colocalization assays and found that, after mitochondrial translocation, Drp1 may promote the excessive opening of the mitochondrial permeability transition pore (mPTP) after hypoxia. Firstly, mitochondrial Drp1 maximumly recognizes mPTP channels by binding Bcl-2-associated X protein (BAX) and a phosphate carrier protein (PiC) in the mPTP. Then, leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) is recruited, whose kinase activity is inhibited by direct binding with mitochondrial Drp1 after hypoxia. Subsequently, the mPTP-related protein hexokinase 2 (HK2) is inactivated at Thr-473 and dissociates from the mitochondrial membrane, ultimately causing structural disruption and overopening of mPTP, which aggravates mitochondrial and cellular dysfunction after hypoxia. Thus, our study interprets the dual direct regulation of mitochondrial Drp1 on mitochondrial morphology and functions after hypoxia and proposes a new mitochondrial fission-independent mechanism for the role of Drp1 after its translocation in hypoxic injury.
Found 
Found 

Top-30

Journals

1
2
3
Frontiers in Pharmacology
3 publications, 5.26%
Frontiers in Immunology
2 publications, 3.51%
Molecular Neurobiology
2 publications, 3.51%
JACC: Basic to Translational Science
2 publications, 3.51%
Military Medical Research
2 publications, 3.51%
Advanced Science
2 publications, 3.51%
Biomedicine and Pharmacotherapy
2 publications, 3.51%
Proceedings of the National Academy of Sciences of the United States of America
2 publications, 3.51%
Cell Death Discovery
2 publications, 3.51%
Antioxidants
1 publication, 1.75%
International Journal of Molecular Sciences
1 publication, 1.75%
Nature Reviews Cardiology
1 publication, 1.75%
Postharvest Biology and Technology
1 publication, 1.75%
Biochimica et Biophysica Acta - Bioenergetics
1 publication, 1.75%
Chemico-Biological Interactions
1 publication, 1.75%
Molecular and Cellular Neurosciences
1 publication, 1.75%
Evidence-based Complementary and Alternative Medicine
1 publication, 1.75%
BioMed Research International
1 publication, 1.75%
Oxidative Medicine and Cellular Longevity
1 publication, 1.75%
Journal of Cell Science
1 publication, 1.75%
American Journal of Pathology
1 publication, 1.75%
International Immunopharmacology
1 publication, 1.75%
Experimental and Therapeutic Medicine
1 publication, 1.75%
Environmental Pollution
1 publication, 1.75%
Pharmaceutical Biology
1 publication, 1.75%
Phytomedicine
1 publication, 1.75%
Anti-Cancer Agents in Medicinal Chemistry
1 publication, 1.75%
Heliyon
1 publication, 1.75%
Life
1 publication, 1.75%
1
2
3

Publishers

2
4
6
8
10
12
14
16
18
20
Elsevier
19 publications, 33.33%
Springer Nature
8 publications, 14.04%
Frontiers Media S.A.
7 publications, 12.28%
MDPI
4 publications, 7.02%
Wiley
4 publications, 7.02%
Hindawi Limited
3 publications, 5.26%
Bentham Science Publishers Ltd.
2 publications, 3.51%
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 3.51%
The Company of Biologists
1 publication, 1.75%
Spandidos Publications
1 publication, 1.75%
Taylor & Francis
1 publication, 1.75%
Cold Spring Harbor Laboratory
1 publication, 1.75%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 1.75%
Academia Brasileira de Ciencias
1 publication, 1.75%
2
4
6
8
10
12
14
16
18
20
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
57
Share
Cite this
GOST |
Cite this
GOST Copy
Duan C. et al. Mitochondrial Drp1 recognizes and induces excessive mPTP opening after hypoxia through BAX-PiC and LRRK2-HK2 // Cell Death and Disease. 2021. Vol. 12. No. 11. 1050
GOST all authors (up to 50) Copy
Duan C., kuang L., Chen H., Xiang X., Liu J., Li Q., Peng X., Zhou Y., Wang H., Liu L., Li T. Mitochondrial Drp1 recognizes and induces excessive mPTP opening after hypoxia through BAX-PiC and LRRK2-HK2 // Cell Death and Disease. 2021. Vol. 12. No. 11. 1050
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41419-021-04343-x
UR - https://doi.org/10.1038/s41419-021-04343-x
TI - Mitochondrial Drp1 recognizes and induces excessive mPTP opening after hypoxia through BAX-PiC and LRRK2-HK2
T2 - Cell Death and Disease
AU - Duan, ChenYang
AU - kuang, Lei
AU - Chen, Hong
AU - Xiang, Xinming
AU - Liu, Jiancang
AU - Li, Qinghui
AU - Peng, XiaoYong
AU - Zhou, Yuanqun
AU - Wang, Hongchen
AU - Liu, Liangming
AU - Li, Tao
PY - 2021
DA - 2021/11/05
PB - Springer Nature
IS - 11
VL - 12
PMID - 34741026
SN - 2041-4889
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Duan,
author = {ChenYang Duan and Lei kuang and Hong Chen and Xinming Xiang and Jiancang Liu and Qinghui Li and XiaoYong Peng and Yuanqun Zhou and Hongchen Wang and Liangming Liu and Tao Li},
title = {Mitochondrial Drp1 recognizes and induces excessive mPTP opening after hypoxia through BAX-PiC and LRRK2-HK2},
journal = {Cell Death and Disease},
year = {2021},
volume = {12},
publisher = {Springer Nature},
month = {nov},
url = {https://doi.org/10.1038/s41419-021-04343-x},
number = {11},
pages = {1050},
doi = {10.1038/s41419-021-04343-x}
}